In a decisive regulatory intervention to curb self-medication and prevent health risks, the Central Drugs Standard Control Organisation (CDSCO) under the Union Ministry of Health and Family Welfare issued an official advisory restricting the indiscriminate usage of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and antibiotics. Addressing healthcare professionals, hospital authorities, and pharmaceutical retailers nationwide, the advisory mandated that painkillers listed under Schedule H and antibiotic formulations classified under Schedule H1 must be dispensed strictly upon valid prescriptions issued by registered medical practitioners. Directorate General of Health Services (DGHS) officials emphasized that non-prescribed intake of heavy analgesics and antimicrobial agents contributes significantly to severe gastrointestinal complications, organ toxicity, and escalating drug resistance across diverse patient demographics. State drug control regulators have been instructed to conduct routine hospital audits, inspect retail pharmacy records, and institute disciplinary actions against non-compliant drug distribution networks. Medical experts and bioethics groups commended the national health directive, affirming that enforcing strict prescription compliance protects patient safety while preserving the long-term clinical efficacy of essential therapeutic medicines.

CDSCO Issues Nationwide Advisory to Curb OTC Abuse

In response to escalating public health concerns surrounding drug-induced organ damage and superbug emergence, the Central Drugs Standard Control Organisation (CDSCO)—under the Directorate General of Health Services (DGHS)—issued a binding circular enforcing strict regulatory protocols on non-steroidal anti-inflammatory drugs (NSAIDs) and antimicrobial agents. The directive targets over-the-counter (OTC) over-reliance on analgesics and indiscriminate antibiotic use, which health authorities linked directly to spikes in chronic kidney disease, acute renal failure, and treatment-resistant bacterial infections nationwide.

Overview: CDSCO Directives on Painkillers & Antibiotics Regulation

Regulation ParameterStatutory Framework & Clinical Mandate
Regulatory AuthorityCentral Drugs Standard Control Organisation (CDSCO)
Statutory Rule BasisDrugs Rules, 1945 under Drugs and Cosmetics Act, 1940
NSAID ClassificationSchedule H (Prescription of Registered Practitioner required)
Antibiotic ClassificationSchedule H1 (Mandatory prescription + separate register maintenance)
Primary Clinical RisksChronic Kidney Disease (CKD) & Antimicrobial Resistance (AMR)
Retailer / Hospital MandateTotal ban on facilitating self-medication; institutional stewardship

Enforcing Schedule H and H1 Prescription Rules for Pharmacies

The CDSCO emphasized that most NSAIDs—including widely consumed painkillers such as diclofenac, aceclofenac, ibuprofen, and mefenamic acid—fall squarely under Schedule H of the Drugs Rules, 1945. Under Rule 97, these formulations cannot be sold at retail without a valid prescription from a Registered Medical Practitioner (RMP).

Similarly, third-generation cephalosporins, fluoroquinolones, and critical reserve antibiotics fall under Schedule H1, carrying explicit package warnings that they are dangerous to consume without direct medical oversight. Retailers and chemists were instructed to cease facilitating self-medication, maintain dedicated Schedule H1 registers recording patient details and prescriber information, and uphold warning labels. State and Union Territory Drug Controllers were empowered to conduct random audits and initiate legal prosecution against non-compliant retail pharmacies.

Clinical Guidelines for Doctors and Hospital Stewardship

For medical practitioners, the health ministry outlined clear prescribing principles to reduce avoidable adverse drug reactions:

  • Lowest Effective Dose: Physicians must prescribe NSAIDs at the lowest effective dose for the shortest possible duration, particularly in elderly patients or those with underlying hypertension, diabetes, cardiovascular conditions, or existing renal impairment.

  • Judicious Antimicrobial Stewardship: Clinicians were instructed to avoid empirical antibiotic prescribing for uncomplicated viral upper-respiratory tract infections. Microbiological testing and local susceptibility patterns must guide targeted antibiotic selection rather than broad-spectrum combination therapy.

  • Institutional Systems: Hospitals and healthcare centers are required to establish internal Prescription Review Committees and active Antimicrobial Stewardship Programs (AMSP) to monitor hospital-wide drug utilization.

The public advisory concluded with a direct appeal to citizens, warning against repeated, unverified use of over-the-counter painkillers or sharing leftover antibiotics. Patients experiencing recurrent pain, fever, or inflammatory symptoms were advised to seek formal clinical evaluation rather than relying on self-administered pharmacotherapy.